Recently, using a biobank, prepared with driver genes, of CAFs extracted from biopsies of NSCLC patients, researchers classified CAFS into three subtypes based on resistance to EGFR-TKIs. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.